AI assistant
Sending…
WESTWATER RESOURCES, INC. — Director's Dealing 2014
Feb 19, 2014
34414_dirs_2014-02-19_bcdc3b29-a35e-4165-9bed-86d12edeb4e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: URANIUM RESOURCES INC /DE/ (URRE)
CIK: 0000839470
Period of Report: 2013-03-05
Reporting Person: Kaiser Marvin K (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-05 | Common Stock | X | 4311 | $2.55 | Acquired | 18644 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-05 | Subscription Rights (right to buy) | $2.55 | X | 4311 | Acquired | 2013-02-27 | Common stock (4311) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $113.20 | 2017-07-12 | Common Stock (5000) | 5000 | Direct |
| Stock Option (right to buy) | $41.00 | 2018-06-04 | Common Stock (5000) | 5000 | Direct |
| Stock Option (right to buy) | $14.90 | 2019-06-03 | Common Stock (5000) | 5000 | Direct |
| Stock Option (right to buy) | $17.30 | 2021-06-07 | Common Stock (1666) | 1666 | Direct |
Footnotes
F1: Stock options granted under 2004 Directors Plan. Shares vest 25% annually beginning one year from date of grant.
F2: Share amounts and per share price have been restated to reflect the 1-for-10 reverse stock split for URRE which was made effective January 22, 2013.
F3: Includes shares of common stock acquired pursuant to the exercise of an over-subscription privilege.
F4: 311 shares were unintentionally omitted from the reporting person's original Form 4 filed on March 7, 2013 and a subsequent Form 4 filed on June 6, 2013.
More from WESTWATER RESOURCES, INC.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
May 12
Investor Presentation
2026
Apr 9
Regulatory Filings
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Mar 31
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 19
Investor Presentation
2026
Jan 29
Director's Dealing
2026
Jan 20